← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cerrx, Inc.
Lubbock, TX
$1,312,055
Total funding
1
Grants
Funding over time
peak $648K · FY2014–18$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,312,055 · 1
By mechanism
R44$1,312,055 · 1
Investigators at Cerrx, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A Phase I trial combining IV fenretinide and IV safingol to target overproduction$648,029
R44 · FY2017 · CA
A Phase I trial combining IV fenretinide and IV safingol to target overproduction$473,425
R44 · FY2018 · CA
A Phase I trial combining IV fenretinide and IV safingol to target overproduction$190,601
R44 · FY2014 · CA